KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Capital Expenditures (2017 - 2026)

Johnson & Johnson's Capital Expenditures history spans 18 years, with the latest figure at $1.0 billion for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 31.95% to $1.0 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $5.1 billion, a 15.28% increase, with the full-year FY2025 number at $4.8 billion, up 9.22% from a year prior.
  • Capital Expenditures hit $1.0 billion in Q1 2026 for Johnson & Johnson, down from $1.8 billion in the prior quarter.
  • Over the last five years, Capital Expenditures for JNJ hit a ceiling of $1.8 billion in Q4 2025 and a floor of $607.0 million in Q2 2022.
  • Historically, Capital Expenditures has averaged $1.1 billion across 5 years, with a median of $1.0 billion in 2025.
  • Biggest five-year swings in Capital Expenditures: soared 42.17% in 2023 and later decreased 13.17% in 2024.
  • Tracing JNJ's Capital Expenditures over 5 years: stood at $607.0 million in 2022, then surged by 161.78% to $1.6 billion in 2023, then grew by 1.45% to $1.6 billion in 2024, then grew by 13.96% to $1.8 billion in 2025, then plummeted by 42.9% to $1.0 billion in 2026.
  • Business Quant data shows Capital Expenditures for JNJ at $1.0 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.2 billion in Q3 2025.